We are live on ! Find out more
WG

Winton Group Portfolio holdings

AUM $3.09B
1-Year Est. Return 40.4%
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.72%
AUM
$1.75B
AUM Growth
+$368M
Cap. Flow
+$219M
Cap. Flow %
12.52%
Top 10 Hldgs %
21.43%
Holding
1,497
New
198
Increased
649
Reduced
507
Closed
137

Sector Composition

Rank Sector Weight
1 Financials 15.87%
2 Consumer Discretionary 12.22%
3 Technology 11.16%
4 Industrials 9.83%
5 Healthcare 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
1326
DELISTED
eMagin Corporation
EMAN
$123K 0.01%
32,898
+7,965
+32% +$26.8K
TPST icon
1327
Tempest Therapeutics
TPST
$16.6M
$112K 0.01%
479
+91
+23% +$36.8K
ASRT
1328
DELISTED
Assertio
ASRT
$109K 0.01%
2,669
-304
-10% -$15.1K
EGAN icon
1329
eGain
EGAN
$203M
$107K 0.01%
+11,300
New +$126K
TRVN
1330
DELISTED
Trevena, Inc.
TRVN
$105K 0.01%
94
+2
+2% +$2.77K
LCTX icon
1331
Lineage Cell Therapeutics
LCTX
$286M
$103K 0.01%
44,013
+9,242
+27% +$22.2K
RDI icon
1332
Reading International Class A
RDI
$35.2M
$103K 0.01%
18,568
-1,135
-6% -$7.56K
SXC icon
1333
SunCoke Energy
SXC
$799M
$101K 0.01%
+14,366
New +$88.7K
TREC
1334
DELISTED
Trecora Resources
TREC
$100K 0.01%
12,857
+2,656
+26% +$19.3K
STSA
1335
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$99K 0.01%
16,793
+4,882
+41% +$29.6K
MUX icon
1336
McEwen Inc
MUX
$1.18B
$97K 0.01%
9,347
-3,711
-28% -$40.7K
MTNB icon
1337
Matinas BioPharma
MTNB
$1.72M
$93K 0.01%
1,767
-146
-8% -$9.79K
LITS
1338
Lite Strategy Inc
LITS
$29.6M
$90K 0.01%
1,306
-45
-3% -$3.15K
YCBD icon
1339
cbdMD
YCBD
$5.94M
$88K 0.01%
59
-15
-20% -$21.8K
AMRX icon
1340
Amneal Pharmaceuticals
AMRX
$5.71B
$84K ﹤0.01%
+12,536
New +$69.5K
ZSAN
1341
DELISTED
Zosano Pharma Corporation
ZSAN
$80K ﹤0.01%
1,845
-66
-3% -$2.76K
GERN icon
1342
Geron
GERN
$949M
$73K ﹤0.01%
46,258
+16,745
+57% +$29.9K
METC icon
1343
Ramaco Resources Class A
METC
$645M
$69K ﹤0.01%
16,938
-2,229
-12% -$8.46K
MITT
1344
TPG Mortgage Investment Trust
MITT
$201M
$67K ﹤0.01%
5,503
-13,564
-71% -$154K
PULM icon
1345
Pulmatrix
PULM
$5.73M
$67K ﹤0.01%
2,517
+661
+36% +$20.2K
UTI icon
1346
Universal Technical Institute
UTI
$1.47B
$65K ﹤0.01%
11,049
-148
-1% -$914
CNCE
1347
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$60K ﹤0.01%
+12,099
New +$97.8K
NBRV
1348
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$55K ﹤0.01%
1,328
+274
+26% +$17K
RIG icon
1349
Transocean
RIG
$6.33B
$54K ﹤0.01%
+15,075
New +$52.4K
PHX
1350
DELISTED
PHX Minerals
PHX
$51K ﹤0.01%
17,603
+785
+5% +$2.4K

Similar funds

Winton Group's Q1 2021 Portfolio in Review

As of Q1 2021, Winton Group held 1,497 positions worth $1.75B, up 27% from $1.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Winton Group deployed $219M of net new capital in Q1 2021, opening 198 new positions and adding to 649 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 190,876 shares worth $14M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was State Street Consumer Discretionary Select Sector SPDR ETF, an estimated $9.87M trimmed.

  • Winton Group's largest Q1 2021 buy was State Street Communication Services Select Sector SPDR ETF: 190,876 shares worth $14M.
  • Winton Group added most to State Street Industrial Select Sector SPDR ETF in Q1 2021, an estimated $38.1M increase.
  • Winton Group's biggest Q1 2021 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $9.87M.
  • Winton Group fully exited Varian Medical Systems, Inc. in Q1 2021, selling an estimated $13.1M.
  • Winton Group's ten largest holdings make up 21% of its $1.75B portfolio in Q1 2021.
  • Winton Group opened 198 new positions and closed 137 in Q1 2021.
  • Winton Group's portfolio value rose 27% quarter-over-quarter to $1.75B.

Based on Winton Group's 13F filing for Q1 2021, filed 21 Jul 2021.